Berrino Emanuela, Michelet Bastien, Martin-Mingot Agnès, Carta Fabrizio, Supuran Claudiu T, Thibaudeau Sébastien
University of Florence, NEUROFARBA Dept., Sezione di Scienze Farmaceutiche e Nutraceutiche, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
Superacid Group in "Organic Synthesis" Team, Université de Poitiers, CNRS UMR 7285 IC2MP, Bât. B28, 4 rue Michel Brunet, TSA 51106, 86073, Poitiers Cedex 09, France.
Angew Chem Int Ed Engl. 2021 Oct 18;60(43):23068-23082. doi: 10.1002/anie.202103211. Epub 2021 Aug 7.
The insertion of fluorine atoms and/or fluoroalkyl groups can lead to many beneficial effects in biologically active molecules, such as enhanced metabolic stability, bioavailability, lipophilicity, and membrane permeability, as well as a strengthening of protein-ligand binding interactions. However, this "magic effect" of fluorine atom(s) insertion can often be meaningless. Taking advantage of the wide range of data coming from the quest for carbonic anhydrase (CA) fluorinated inhibitors, this Minireview attempts to give "general guidelines" on how to wisely insert fluorine atom(s) within an inhibitor moiety to precisely enhance or disrupt ligand-protein interactions, depending on the target location of the fluorine substitution in the ligand. Multiple approaches such as ITC, kinetic and inhibition studies, X-ray crystallography, and NMR spectroscopy are useful in dissecting single binding contributions to the overall observed effect. The exploitation of innovative directions made in the field of protein and ligand-based fluorine NMR screening is also discussed to avoid misconduct and finely tune the exploitation of selective fluorine atom insertion in the future.
在生物活性分子中引入氟原子和/或氟烷基可带来许多有益效果,例如增强代谢稳定性、生物利用度、亲脂性和膜通透性,以及加强蛋白质-配体结合相互作用。然而,这种引入氟原子的“神奇效果”往往可能毫无意义。利用在寻找碳酸酐酶(CA)氟化抑制剂过程中获得的大量数据,本微型综述试图给出“通用指南”,说明如何根据氟取代在配体中的目标位置,在抑制剂部分明智地引入氟原子,以精确增强或破坏配体-蛋白质相互作用。等温滴定量热法(ITC)、动力学和抑制研究、X射线晶体学以及核磁共振波谱等多种方法,对于剖析对整体观察到的效果的单一结合贡献很有用。还讨论了在基于蛋白质和配体的氟核磁共振筛选领域所取得的创新方向的应用,以避免不当行为,并在未来精细调整选择性氟原子插入的应用。